by Clinical Neuropsychologist | Thursday, April 3, 2025 | Paediatric Neuropsychology
. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: | April 3, 2025 Neuro-Paediatric Previous Page
by Clinical Neuropsychologist | Thursday, April 3, 2025 | Paediatric Neuropsychology
. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: | April 3, 2025 Neuro-Paediatric Previous Page
by Clinical Neuropsychologist | Tuesday, April 1, 2025 | Paediatric Neuropsychology
. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: | April 1, 2025 Neuro-Paediatric Previous Page
by Clinical Neuropsychologist | Thursday, March 27, 2025 | Paediatric Neuropsychology
. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: | March 27, 2025 Neuro-Paediatric Previous Page
by Clinical Neuropsychologist | Tuesday, December 10, 2024 | Paediatric Neuropsychology
Adolescents with sickle cell disease (SCD) are at risk of executive functioning (EF) deficits that may negatively impact medication adherence. EF studies in SCD have been primarily performance-based; however, rating-based assessments may inform the ability to...
by Clinical Neuropsychologist | Tuesday, December 10, 2024 | Paediatric Neuropsychology
The Gilliam Autism Rating Scales-3rd Edition (GARS-3) is widely utilized, but evidence regarding its psychometric properties is limited and equivocal. The current study attempted to create a shorter GARS-3, to be utilized for screening purposes, via exploratory factor...